Hector DeLuca - Deerfield WI, US Ehren Rudolph - Madison WI, US Laura Bloss - Oxnard CA, US Julia Zella - Madison WI, US
International Classification:
A61K 31/59
US Classification:
514167000
Abstract:
A method of delaying the onset or reducing the severity of diabetes in a human patient is disclosed. In one embodiment, the invention comprises the step of orally administering to the human patient an effective amount of a vitamin D compound such as the onset of diabetes or diabetes symptoms is slowed.
Amgen 2007 - 2011
Executive Director, Global Development
Amgen 2007 - 2011
Executive Director Regulatory Affairs
Amgen 2005 - 2007
Director, Global Development
Amgen 2004 - 2005
Associate Director, Development
Amgen 2001 - 2004
Senior Clinical Research Manager
Education:
University of Wisconsin - Madison 1993 - 1997
Doctorates, Doctor of Philosophy, Biochemistry, Philosophy
University of Virginia 1989 - 1993
Bachelors, Chemistry
Skills:
Clinical Development Biotechnology Clinical Trials Pharmaceutical Industry Regulatory Submissions Drug Development Regulatory Affairs Biopharmaceuticals Clinical Research Oncology Fda Ind Life Sciences Gcp Pharmacovigilance Sop Commercialization Medical Affairs Lifesciences Pharmacokinetics Market Access Infectious Diseases